Skip to main content
Equibles
MTNB logo

MTNB · Matinas BioPharma Holdings, Inc.

Track MTNB — free

Use MTNB with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.18 +0.00 (+0.55%) At close · Sep 4
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The Company does not believe that the cash and cash equivalents on hand are sufficient to fund planned operations for a period of at least twelve months from the filing date of these financial statements. As a result, substantial doubt exists about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 13, 2026
Market Cap
$2.67M
Shares
14.69M

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed Type Offering Sold
2025-02-19 New $3,300,000 $1,650,000
Showing 1–1 of 1 filings
Key facts CIK 1582554 CUSIP 576810303 13F (30d) 15 filings 15 filers Visit website Investor relations